Compensatory distal reabsorption drives diuretic resistance in human heart failure

Journal of the American Society of Nephrology

Volumn 28, Issue 11, 2017, Pages 3414-3424

  Rao, Veena S ^a   Planavsky, Noah ^b   Hanberg, Jennifer S ^a   Ahmad, Tariq ^a   Brisco Bacik, Meredith A ^c   Wilson, Francis P ^a   Jacoby, Daniel ^a   Chen, Michael ^a   Tang, W H Wilson ^d   Cherney, David Z I ^e,f   Ellison, David H ^g   Testani, Jeffrey M ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY   (United States)

^c TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d LERNER RESEARCH INSTITUTE   (United States)

^e UNIVERSITY HEALTH NETWORK   (Canada)

^f UNIVERSITY OF TORONTO   (Canada)

^g OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUMETANIDE; FUROSEMIDE; LITHIUM; SODIUM; LOOP DIURETIC AGENT;

AGED; ARTICLE; CLINICAL ASSESSMENT; COHORT ANALYSIS; CONTROLLED STUDY; DRUG ABSORPTION; DRUG EFFECT; EXCRETION FRACTION; FEMALE; HEART FAILURE; HENLE LOOP; HUMAN; IN VIVO STUDY; KIDNEY TUBULE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SODIUM ABSORPTION; SODIUM EXCRETION; URINARY EXCRETION; DRUG RESISTANCE; KIDNEY DISTAL TUBULE; KIDNEY TUBULE ABSORPTION; METABOLISM; PROSPECTIVE STUDY;

AGED; DRUG RESISTANCE; FEMALE; HEART FAILURE; HUMANS; KIDNEY TUBULES, DISTAL; MALE; PROSPECTIVE STUDIES; RENAL REABSORPTION; SODIUM POTASSIUM CHLORIDE SYMPORTER INHIBITORS;

EID: 85032635388     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2016111178     Document Type: Article

References (50)

1. Gheorghiade M, Filippatos G, De Luca L, Burnett J: Congestion in acute heart failure syndromes: An essential target of evaluation and treatment. Am J Med 119[Suppl 1]: S3-S10, 2006.
2. Gheorghiade M, Follath F, Ponikowski P, Barsuk JH, Blair JE, Cleland JG, Dickstein K, Drazner MH, Fonarow GC, Jaarsma T, Jondeau G, Sendon JL, Mebazaa A, Metra M, Nieminen M, Pang PS, Seferovic P, Stevenson LW, van Veldhuisen DJ, Zannad F, Anker SD, Rhodes A, McMurray JJ, Filippatos G; European Society of Cardiology; European Society of Intensive Care Medicine: Assessing and grading congestion in acute heart failure: A scientific statement from the acute heart failure committee of the heart failure association of the European Society of Cardiology and endorsed by the European Society of Intensive Care Medicine. Eur J Heart Fail 12: 423-433, 2010.
3. Gheorghiade M, Pang PS: Acute heart failure syndromes. J Am Coll Cardiol 53: 557-573, 2009.
4. Gheorghiade M, Vaduganathan M, Fonarow GC, Bonow RO: Rehospitalization for heart failure: Problems and perspectives. J AmColl Cardiol 61: 391-403, 2013.
5. Iyengar S, Abraham WT: Diuretic resistance in heart failure. Curr Heart Fail Rep 3: 41-45, 2006.
6. Ellison DH: Diuretic therapy and resistance in congestive heart failure. Cardiology 96: 132-143, 2001.
7. Testani JM, Brisco MA, Turner JM, Spatz ES, Bellumkonda L, Parikh CR, Tang WH: Loop diuretic efficiency: A metric of diuretic responsiveness with prognostic importance in acute decompensated heart failure. Circ Heart Fail 7: 261-270, 2014.
8. Valente MA, Voors AA, Damman K, Van Veldhuisen DJ, Massie BM, O'Connor CM, Metra M, Ponikowski P, Teerlink JR, Cotter G, Davison B, Cleland JG, Givertz MM, Bloomfield DM, Fiuzat M, Dittrich HC, Hillege HL: Diuretic response in acute heart failure: Clinical characteristics and prognostic significance. Eur Heart J 35: 1284-1293, 2014.
9. Brenner BM, Rector FC: Brenner & Rector's The Kidney, Philadelphia, Saunders Elsevier, 2008.
10. Ellison DH, Velázquez H, Wright FS: Adaptation of the distal convoluted tubule of the rat. Structural and functional effects of dietary salt intake and chronic diuretic infusion. J Clin Invest 83: 113-126, 1989.
11. Stanton BA, Kaissling B: Regulation of renal ion transport and cell growth by sodium. Am J Physiol 257: F1-F10, 1989.
12. Reilly RF, Ellison DH: Mammalian distal tubule: Physiology, pathophysiology, and molecular anatomy. Physiol Rev 80: 277-313, 2000.
13. Wilcox CS, Mitch WE, Kelly RA, Skorecki K, Meyer TW, Friedman PA, Souney PF: Response of the kidney to furosemide. I. Effects of salt intake and renal compensation. J Lab ClinMed 102: 450-458, 1983.
14. Kaissling B, Stanton BA: Adaptation of distal tubule and collecting duct to increased sodium delivery. I. Ultrastructure. Am J Physiol 255: F1256-F1268, 1988.
15. Kaissling B, Bachmann S, Kriz W: Structural adaptation of the distal convoluted tubule to prolonged furosemide treatment. Am J Physiol 248: F374-F381, 1985.
16. Abdallah JG, Schrier RW, Edelstein C, Jennings SD, Wyse B, Ellison DH: Loop diuretic infusion increases thiazide-sensitive Na(+)/Cl (-)-cotransporter abundance: Role of aldosterone. J AmSoc Nephrol 12: 1335-1341, 2001.
17. Loon NR, Wilcox CS, Unwin RJ: Mechanism of impaired natriuretic response to furosemide during prolonged therapy. Kidney Int 36: 682-689, 1989.
18. Almeshari K, Ahlstrom NG, Capraro FE, Wilcox CS: A volumeindependent component to postdiuretic sodium retention in humans. J Am Soc Nephrol 3: 1878-1883, 1993.
19. Epstein M, Lepp BA, Hoffman DS, Levinson R: Potentiation of furosemide by metolazane in refractory edema. Curr Ther Res 21: 656-667, 1977.
20. Oster JR, Epstein M, Smoller S: Combined therapy with thiazide-type and loop diuretic agents for resistant sodiumretention.Ann Intern Med 99: 405-406, 1983.
21. Oimomi M, Takase S, Saeki S: Combination diuretic therapy for severe refractory nephrotic syndrome. Lancet 336: 1004-1005, 1990.
22. Christensen S, Shalmi M, Petersen JS: Lithiumclearance as an indicator of proximal tubular sodium handling during furosemide diuresis. J Pharmacol Exp Ther 246: 753-757, 1988.
23. Koomans HA, Boer WH, Dorhout Mees EJ: Evaluation of lithiumclearance as amarker of proximal tubule sodiumhandling. Kidney Int 36: 2-12, 1989.
24. Cavero PG, Margulies KB, Winaver J, Seymour AA, Delaney NG, Burnett JC Jr.: Cardiorenal actions of neutral endopeptidase inhibition in experimental congestive heart failure. Circulation 82: 196-201, 1990.
25. Dorhout Mees EJ, Beutler JJ, Boer WH, Koomans HA: Does lithium clearance reflect distal delivery in humans? Analysis with furosemide infusion. Am J Physiol 258: F1100-F1104, 1990.
26. Beutler JJ, Boer WH, Koomans HA, Dorhout Mees EJ: Comparative study of the effects of furosemide, ethacrynic acid and bumetanide on the lithium clearance and diluting segment reabsorption in humans. J Pharmacol Exp Ther 260: 768-772, 1992.
27. Unwin RJ, Walter SJ, Shirley DG: Lithium reabsorption in perfused loops of Henle: Effects of perfusion rate and bumetanide. Am J Physiol 266: F806-F812, 1994.
28. Boer WH, Fransen R, Shirley DG, Walter SJ, Boer P, Koomans HA: Evaluation of the lithium clearance method: Direct analysis of tubular lithium handling by micropuncture. Kidney Int 47: 1023-1030, 1995.
29. Olsen NV, Fogh-Andersen N, Strandgaard S, Leyssac PP:Endogenous versus exogenous lithium clearance for evaluation of dopamine-induced changes in renal tubular function. Clin Sci (Lond) 90: 511-515, 1996.
30. Zhang Y, Magyar CE, Norian JM, Holstein-Rathlou NH, Mircheff AK, McDonough AA: Reversible effects of acute hypertension on proximal tubule sodium transporters. Am J Physiol 274: C1090-C1100, 1998.
31. Würzner G, Chiolero A, Maillard M, Nussberger J, Hayoz D, Brunner HR, Burnier M: Renal and neurohormonal responses to increasing levels of lower body negative pressure in men. Kidney Int 60: 1469-1476, 2001.
32. Sansoè G, Biava AM, Silvano S, Ferrari A, Rosina F, Smedile A, Touscoz A, Bonardi L, Rizzetto M: Renal tubular events following passage from the supine to the standing position in patients with compensated liver cirrhosis: Loss of tubuloglomerular feedback. Gut 51: 736-741, 2002.
33. Hiranyachattada S, Saetew S, Harris PJ: Acute effects of candesartan on rat renal haemodynamics and proximal tubular reabsorption. Clin Exp Pharmacol Physiol 32: 714-720, 2005.
34. Seidlerová J, Staessen JA, Maillard M, Nawrot T, Zhang H, Bochud M, Kuznetsova T, Richart T, Van Bortel LM, Struijker-Boudier HA, Manunta P, Burnier M, Fagard R, Filipovský J: Association between arterial properties and renal sodium handling in a general population. Hypertension 48: 609-615, 2006.
35. Eap CB, Bochud M, Elston RC, Bovet P, Maillard MP, Nussberger J, Schild L, Shamlaye C, Burnier M: CYP3A5 and ABCB1 genes influence blood pressure and response to treatment, and their effect is modified by salt. Hypertension 49: 1007-1014, 2007.
36. Chagnac A, Herman M, Zingerman B, Erman A, Rozen-Zvi B, Hirsh J, Gafter U: Obesity-induced glomerular hyperfiltration: Its involvement in the pathogenesis of tubular sodium reabsorption. Nephrol Dial Transplant 23: 3946-3952, 2008.
37. Favre GA, Nau V, Kolb I, Vargas-Poussou R, Hannedouche T, Moulin B: Localization of tubular adaptation to renal sodium loss in Gitelman syndrome. Clin J Am Soc Nephrol 7: 472-478, 2012.
38. Skov J, Dejgaard A, Frøkiær J, Holst JJ, Jonassen T, Rittig S, Christiansen JS: Glucagon-like peptide-1 (GLP-1): Effect on kidney hemodynamics and renin-angiotensin-aldosterone system in healthy men. J Clin Endocrinol Metab 98: E664-E671, 2013.
39. Zou J, Li Y, Yan CH, Wei FF, Zhang L, Wang JG: Blood pressure in relation to interactions between sodium dietary intake and renal handling. Hypertension 62: 719-725, 2013.
40. Atherton JC, Green R, Hughes S, McFall V, Sharples JA, Solomon LR, Wilson L: Lithium clearance in man: Effects of dietary salt intake, acute changes in extracellular fluid volume, amiloride and frusemide. Clin Sci (Lond) 73: 645-651, 1987.
41. Rombolà G, Colussi G, De Ferrari ME, Surian M, Malberti F, Minetti L: Clinical evaluation of segmental tubular reabsorption of sodium and fluid in man: Lithium vs free water clearances. Nephrol Dial Transplant 2: 212-218, 1987.
42. Thomsen K: Lithiumclearance: A newmethod for determining proximal and distal tubular reabsorption of sodiumand water. Nephron 37: 217- 223, 1984.
43. Thomsen K, Olesen OV: Renal lithium clearance as a measure of the delivery of water and sodiumfromthe proximal tubule in humans.Am J Med Sci 288: 158-161, 1984.
44. Brater DC: Diuretic therapy. N Engl J Med 339: 387-395, 1998.
45. Ter Maaten JM, Rao VS, Hanberg JS, Perry Wilson F, Bellumkonda L, Assefa M, Sam Broughton J, D'Ambrosi J, Wilson Tang WH, Damman K, Voors AA, Ellison DH, Testani JM: Renal tubular resistance is the primary driver for loop diuretic resistance in acute heart failure [published online ahead of print January 19, 2017]. Eur J Heart Fail doi:10.1002/ejhf.757.
46. Parikh CR, Coca SG, Thiessen-Philbrook H, Shlipak MG, Koyner JL, Wang Z, Edelstein CL, Devarajan P, Patel UD, Zappitelli M, Krawczeski CD, Passik CS, Swaminathan M, Garg AX; TRIBE-AKI Consortium: Postoperative biomarkers predict acute kidney injury and poor outcomes after adult cardiac surgery. J Am Soc Nephrol 22: 1748-1757, 2011.
47. Hanberg JS, Rao V, Ter Maaten JM, Laur O, Brisco MA, Perry Wilson F, Grodin JL, Assefa M, Samuel Broughton J, Planavsky NJ, Ahmad T, Bellumkonda L, Tang WH, Parikh CR, Testani JM: Hypochloremia and diuretic resistance in heart failure: Mechanistic insights. Circ Heart Fail 9: e003180, 2016.
48. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration): A new equation to estimate glomerular filtration rate. Ann Intern Med 150: 604-612, 2009.
49. Ward A, Heel RC: Bumetanide. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use. Drugs 28: 426-464, 1984.
50. Vargo DL, Kramer WG, Black PK, Smith WB, Serpas T, Brater DC: Bioavailability, pharmacokinetics, and pharmacodynamics of torsemide and furosemide in patients with congestive heart failure. Clin Pharmacol Ther 57: 601-609, 1995.